CA
NZ
UK
AU
IND
US
Innventure (NASDAQ:INV), a company with two subsidiaries, Accelsius (two-phase cooling for data centres) and Refinity (plastic-to-olefins recycling), traded at USD 0.3200 in the pre-market snapshot. No company-specific announcement dated Tuesday, October 27, 2026 accompanied the move. The most recent release, dated Thursday, October 8, …
Net interest margin was 3.86% and loans grew about 7.2% annualized to USD 6.78 billion, with deposits up about 7.7% to USD 7.38 billion. The difference between core and GAAP EPS reflects merger and conversion costs after Progressive Bank moved onto the b1BANK platform …
Bitcoin (BTC) fell 1.2% to about USD 79,800 on Monday, October 26, 2026, slipping just under the round USD 80,000 level that traders watch. US spot Bitcoin exchange-traded funds recorded USD 169 million of net outflows, meaning more money left the funds than entered. …
The net loss reflects a USD 20.2 million one-time charge for retiring 9.25% notes, replaced by USD 230 million of 2.875% exchangeable notes that cut the average cost of debt to 4.78% from 5.58%. Leasing was strong, with 406 thousand square feet signed, a …
Sunshine Biopharma (NASDAQ:SBFM), a Canadian generic pharmaceutical seller with oncology and antiviral research programmes, traded in a pre-market snapshot. No company-specific announcement dated on or just before Tuesday, October 27, 2026 was identified. The most recent corporate event is the company's release of Thursday, …
On Monday, October 26, 2026, a media report said that DoorDash (NASDAQ:DASH) is in talks to acquire the company that operates the Instacart grocery delivery platform, and that a deal could be agreed this week. DoorDash shares fell 6.10%, and shares of Maplebear (NASDAQ:CART) …
Revenue rose USD 490 million while fuel expense rose USD 329 million, simple arithmetic on the release, and unit costs excluding fuel rose 7.0%. The net loss was USD 257 million. Fourth quarter guidance calls for unit revenue up 18.0% to 22.0% on fuel …
Moderna (NASDAQ:MRNA) and Merck reported Phase 3 results from the INTerpath-001 trial of an individualized neoantigen therapy, a personalized cancer vaccine, in melanoma. The trial showed a recurrence-free survival hazard ratio of 0.58 and a distant metastasis-free survival hazard ratio of 0.62. The company …
Innventure (NASDAQ:INV), a company with two subsidiaries, Accelsius (two-phase cooling for data centres) and Refinity (plastic-to-olefins recycling), traded in a pre-market snapshot. No company-specific announcement dated Tuesday, October 27, 2026 accompanied the move. The most recent release, dated Thursday, October 8, 2026, established the …
The third quarter is an upcoming event, not yet reported at the time of writing, and no consensus EPS was available. The best anchor is second quarter FFO of USD 0.90, which rose from USD 0.85 on slightly higher revenue of USD 25.0 million …
Please wait processing your request...